Danaher Corp
NYSE:DHR

  • LAST PRICE
    251.6850
  • TODAY'S CHANGE (%)
    -0.1150 (-0.0457%)
  • Bid / Lots
    251.6000/ 1
  • Ask / Lots
    251.8200/ 3
  • Open / Previous Close
    254.4400 / 251.8000
  • Day Range
    249.2900
    254.5200
  • 52 Week Range
    233.7080
    333.9600
  • Volume
    859,291

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Advanced Medical Equipment Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
DHR
Danaher Corp
183.1B
29.5x
+22.51%
TMO
Thermo Fisher Scientific Inc
217.3B
28.8x
+30.73%
PHG
Koninklijke Philips NV
21.9B
44.9x
-4.27%
BSX
Boston Scientific Corp
56.1B
75.6x
+22.21%
ISRG
Intuitive Surgical Inc
78.6B
49.1x
+17.42%
EW
Edwards Lifesciences Corp
58.6B
39.1x
+22.26%
As of 2022-05-23

Company Information

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Contact Information

Headquarters
2200 Pennsylvania Ave NW Ste 800wWASHINGTON, DC, United States 20037-1731
Phone
202-828-0850
Fax
202-828-0860

Executives

Chairman of the Board
Steven Rales
President, Chief Executive Officer, Director
Rainer Blair
Co-Founder, Director
Mitchell Rales
Chief Financial Officer, Executive Vice President
Matthew McGrew
Executive Vice President
Jennifer Honeycutt

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$183.1B
Revenue (TTM)
$30.3B
Shares Outstanding
727.1M
Dividend Yield
0.40%
Annual Dividend Rate
1.0000 USD
Ex-Dividend Date
06-23-22
Pay Date
07-29-22
Beta
0.83
EPS
$8.52
Book Value
$63.17
P/E Ratio
29.5x
Price/Sales (TTM)
6.0
Price/Cash Flow (TTM)
21.7x
Operating Margin
24.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.